These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 28910739)

  • 1. Novel ruthenium azo-quinoline complexes with enhanced photonuclease activity in human cancer cells.
    Kaulage MH; Maji B; Pasadi S; Bhattacharya S; Muniyappa K
    Eur J Med Chem; 2017 Oct; 139():1016-1029. PubMed ID: 28910739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dinuclear Organoruthenium Complexes Exhibiting Antiproliferative Activity through DNA Damage and a Reactive-Oxygen-Species-Mediated Endoplasmic Reticulum Stress Pathway.
    Zhao J; Li S; Wang X; Xu G; Gou S
    Inorg Chem; 2019 Feb; 58(3):2208-2217. PubMed ID: 30675781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solvent assisted formation of ruthenium(III) and ruthenium(II) hydrazone complexes in one-pot with potential in vitro cytotoxicity and enhanced LDH, NO and ROS release.
    Jayanthi E; Kalaiselvi S; Padma VV; Bhuvanesh NS; Dharmaraj N
    Dalton Trans; 2016 Jan; 45(4):1693-707. PubMed ID: 26699435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and anticancer properties of ruthenium (II) complexes as potent apoptosis inducers through mitochondrial disruption.
    Wan D; Tang B; Wang YJ; Guo BH; Yin H; Yi QY; Liu YJ
    Eur J Med Chem; 2017 Oct; 139():180-190. PubMed ID: 28800456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of Ru-arene Complexes for Antitumor Drugs.
    Su W; Li Y; Li P
    Mini Rev Med Chem; 2018; 18(2):184-193. PubMed ID: 28494728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrazole appended quinoline-BODIPY based arene ruthenium complexes: their anticancer activity and potential applications in cellular imaging.
    Paitandi RP; Sharma V; Singh VD; Dwivedi BK; Mobin SM; Pandey DS
    Dalton Trans; 2018 Dec; 47(48):17500-17514. PubMed ID: 30507985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, characterization, cellular uptake and apoptosis-inducing properties of two highly cytotoxic cyclometalated ruthenium(II) β-carboline complexes.
    Chen J; Peng F; Zhang Y; Li B; She J; Jie X; Zou Z; Chen M; Chen L
    Eur J Med Chem; 2017 Nov; 140():104-117. PubMed ID: 28923379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Light-activated ruthenium complexes photobind DNA and are cytotoxic in the photodynamic therapy window.
    Wachter E; Heidary DK; Howerton BS; Parkin S; Glazer EC
    Chem Commun (Camb); 2012 Oct; 48(77):9649-51. PubMed ID: 22908094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A GSH-activatable ruthenium(ii)-azo photosensitizer for two-photon photodynamic therapy.
    Zeng L; Kuang S; Li G; Jin C; Ji L; Chao H
    Chem Commun (Camb); 2017 Feb; 53(12):1977-1980. PubMed ID: 28119967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organometallic ruthenium(II)-arene complexes with triphenylphosphine amino acid bioconjugates: Synthesis, characterization and biological properties.
    Pernar M; Kokan Z; Kralj J; Glasovac Z; Tumir LM; Piantanida I; Eljuga D; Turel I; Brozovic A; Kirin SI
    Bioorg Chem; 2019 Jun; 87():432-446. PubMed ID: 30925428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel tetranuclear ruthenium(II) arene complexes showing potent cytotoxic and antimetastatic activity as well as low toxicity in vivo.
    Mohamed Subarkhan MK; Ren L; Xie B; Chen C; Wang Y; Wang H
    Eur J Med Chem; 2019 Oct; 179():246-256. PubMed ID: 31255925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and cytotoxic activities of organometallic Ru(II) diamine complexes.
    Kavukcu SB; Şahin O; Seda Vatansever H; Kurt FO; Korkmaz M; Kendirci R; Pelit L; Türkmen H
    Bioorg Chem; 2020 Jun; 99():103793. PubMed ID: 32278205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of new salicylaldehyde-2-picolinylhydrazone Schiff base compounds of Ru(II), Rh(III) and Ir(III) as in vitro antitumor, antibacterial and fluorescence imaging agents.
    Palepu NR; Nongbri SL; Premkumar JR; Verma AK; Bhattacharjee K; Joshi SR; Forbes S; Mozharivskyj Y; Thounaojam R; Aguan K; Kollipara MR
    J Biol Inorg Chem; 2015 Jun; 20(4):619-38. PubMed ID: 25712889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arene ruthenium complexes as anticancer agents.
    Süss-Fink G
    Dalton Trans; 2010 Feb; 39(7):1673-88. PubMed ID: 20449402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dimetallic Ru(II) arene complexes appended on bis-salicylaldimine induce cancer cell death and suppress invasion via p53-dependent signaling.
    Rahman FU; Bhatti MZ; Ali A; Duong HQ; Zhang Y; Ji X; Lin Y; Wang H; Li ZT; Zhang DW
    Eur J Med Chem; 2018 Sep; 157():1480-1490. PubMed ID: 30282320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, interaction with DNA, cytotoxicity, cell cycle arrest and apoptotic inducing properties of ruthenium(II) molecular "light switch" complexes.
    Shobha Devi C; Anil Kumar D; Singh SS; Gabra N; Deepika N; Kumar YP; Satyanarayana S
    Eur J Med Chem; 2013 Jun; 64():410-21. PubMed ID: 23665797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human topoisomerase inhibition and DNA/BSA binding of Ru(II)-SCAR complexes as potential anticancer candidates for oral application.
    De Grandis RA; de Camargo MS; da Silva MM; Lopes ÉO; Padilha EC; Resende FA; Peccinini RG; Pavan FR; Desideri A; Batista AA; Varanda EA
    Biometals; 2017 Jun; 30(3):321-334. PubMed ID: 28303361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, characterization, and anticancer activity of ruthenium(II)-β-carboline complex.
    Chen Y; Qin MY; Wu JH; Wang L; Chao H; Ji LN; Xu AL
    Eur J Med Chem; 2013; 70():120-9. PubMed ID: 24141202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ruthenium dendrimers against acute promyelocytic leukemia: 
    Michlewska S; Ionov M; Maroto-Díaz M; Szwed A; Ihnatsyeu-Kachan A; Abashkin V; Dzmitruk V; Rogalska A; Denel M; Gapinska M; Shcharbin D; Gomez Ramirez R; de la Mata FJ; Bryszewska M
    Future Med Chem; 2019 Jul; 11(14):1741-1756. PubMed ID: 31287722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New half-sandwich ruthenium(ii) complexes as proteosynthesis inhibitors in cancer cells.
    Ballester FJ; Ortega E; Porto V; Kostrhunova H; Davila-Ferreira N; Bautista D; Brabec V; Domínguez F; Santana MD; Ruiz J
    Chem Commun (Camb); 2019 Jan; 55(8):1140-1143. PubMed ID: 30631876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.